Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Baxter
Argus Health
Dow
Boehringer Ingelheim
Harvard Business School
Julphar
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

DOXAPRAM HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Doxapram Hydrochloride patents expire, and what generic alternatives are available?

Doxapram Hydrochloride is a drug marketed by Athenex Inc and Watson Labs and is included in two NDAs.

The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
Drug patent expirations by year for DOXAPRAM HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE
Synonyms for DOXAPRAM HYDROCHLORIDE
(+-)-1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
081D530
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride
113-07-5
113D075
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+-)-
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone,3-diphenyl-, monohydrochloride
3,3-Diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride
AC-4694
AC1L21NE
AHR 619
AHR-619
AK-55670
AKOS015906444
AOB5785
API0002485
AS-13336
Bio-0166
C24H30N2O2
C24H30N2O2.HCl
CAS-113-07-5
CCG-101076
CCG-221205
CHEBI:59837
CHEMBL1200876
CPD000469229
CTK8F9367
Doxapram HCL
Doxapram hydrochloride [USAN:JAN]
Doxapram hydrochloride anhydrous
DSSTox_CID_27815
DSSTox_GSID_47837
DSSTox_RID_82579
DTXSID9047837
EINECS 204-022-3
FC1271
H927
J-002892
K-0985
LS-138812
MBGXILHMHYLZJT-UHFFFAOYSA-N
MCULE-1905124271
MFCD00072148
MLS001424142
MolPort-005-973-141
NC00326
NCGC00167459-01
NCGC00167459-02
NSC-170958
NSC170958
SAM001246792
SCHEMBL40645
SMR000469229
Stimulexin
Tox21_112463
Tox21_112463_1

US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 076266-001 Jan 10, 2003 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 073529-001 Jan 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Queensland Health
McKinsey
Mallinckrodt
QuintilesIMS
Covington
Deloitte
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.